SAN FRANCISCO--(EON:Enhanced Online News)--SpineVision® announced today that it has appointed James Coyle as Vice President of U.S. Sales for SpineVision Inc.Mr. Coyle has 17+ years of spinal device-related experience with K2M, DePuy Spine andMedtronic Sofamor Danek. He was most recently Western Sales Director for AOI Medical.
“We expect that James Coyle’s considerable experience in the sale of spinal devices for some of the leading companies in our industry will empower him to quickly establish solid relationships with distributors throughout the United States, who will drive market penetration of SpineVision’s great products such as our FDA-cleared PediGuard™ device,” said Stephane Bette, General Manager of SpineVision’s U.S. operations.
Monday, June 17, 2013
RTI Biologics intents to acquire privately held Pioneer Surgical Technology
RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer® Surgical Technology (Pioneer), headquartered in Marquette, Mich. Pioneer is a leading medical technology company that manufactures and distributes metal and synthetic products in the orthopedics, biologics, spine, trauma and cardiothoracic markets. The acquisition of Pioneer supports RTI's strategic initiatives to expand its current implant portfolio into metals and synthetics and to grow direct distribution.
"The combination of RTI and Pioneer is an exciting opportunity for both companies and their employees," said Brian K. Hutchison, RTI president and chief executive officer. "This acquisition is strongly aligned with RTI's long term strategic plan, accelerating new growth opportunities and gross margin expansion. Pioneer has built a strong distribution network for their implants, which will be beneficial when we launch our map3™ cellular allogeneic bone graft later this year. This acquisition will bring immediate scale, allowing us to reach our strategic goals and take advantage of growth opportunities more quickly than either company could do independently."
"We believe the combination of Pioneer and RTI will be a catalyst for continued growth," said Daniel Webber, Pioneer's president and chief executive officer. "The combined company will have a broad portfolio of complementary surgical implants benefiting patients, surgeons and hospitals, as well as advancing the positive momentum we have built at Pioneer. Additionally, RTI's culture of innovation is a great fit with that of our own employees."
"The combination of RTI and Pioneer is an exciting opportunity for both companies and their employees," said Brian K. Hutchison, RTI president and chief executive officer. "This acquisition is strongly aligned with RTI's long term strategic plan, accelerating new growth opportunities and gross margin expansion. Pioneer has built a strong distribution network for their implants, which will be beneficial when we launch our map3™ cellular allogeneic bone graft later this year. This acquisition will bring immediate scale, allowing us to reach our strategic goals and take advantage of growth opportunities more quickly than either company could do independently."
"We believe the combination of Pioneer and RTI will be a catalyst for continued growth," said Daniel Webber, Pioneer's president and chief executive officer. "The combined company will have a broad portfolio of complementary surgical implants benefiting patients, surgeons and hospitals, as well as advancing the positive momentum we have built at Pioneer. Additionally, RTI's culture of innovation is a great fit with that of our own employees."
Saturday, June 15, 2013
Medtronic Announces CE Mark of a New Spinal Instrument
NICE, France - June 13, 2013 - Medtronic, Inc. (NYSE: MDT) announced today the CE Mark (Conformité Européenne) and the European launch of the ReDuX(TM) Plier, a new instrument specially designed for use during osteotomies. With the launch of this first specially-designed surgical instrument in the spinal orthopaedic industry, physicians in the European community may now perform a more controlled osteotomy closure for people with a severe form of spinal curvature.
The new instrument, called ReDuX Plier, has been developed by Medtronic European Product Development Office based in Tolochenaz, Switzerland, following an original invention by Professor Le Huec, chief of the Spine Unit and chair of the Department of Orthopaedics and Traumatology at the Bordeaux University Hospital, France.Adult spinal deformity poses many challenges to spine surgeons. In particular, a substantial imbalance in the sagittal plane sometimes cannot be corrected solely with a standard arthrodesis procedure. In these cases, spinal osteotomies must be performed to restore balance in both the sagittal and the coronal planes.
The new instrument, called ReDuX Plier, has been developed by Medtronic European Product Development Office based in Tolochenaz, Switzerland, following an original invention by Professor Le Huec, chief of the Spine Unit and chair of the Department of Orthopaedics and Traumatology at the Bordeaux University Hospital, France.Adult spinal deformity poses many challenges to spine surgeons. In particular, a substantial imbalance in the sagittal plane sometimes cannot be corrected solely with a standard arthrodesis procedure. In these cases, spinal osteotomies must be performed to restore balance in both the sagittal and the coronal planes.
Thursday, June 13, 2013
Aurora Spine Announces the Appointment Mr. Richard Moss VP of International Business Development
Carlsbad, CA- June 11th, 2013- Aurora Spine today announces the appointment of Mr. Richard Moss, VP of International Business Development. Mr. Moss has been VicePresident of International Sales at Doctors Research Group, Inc. since February 2009.He served as Director of Sales (Europe) for TranS1, Inc., a publicly traded US medical device company based in Wilmington NC, focusing on developing innovative, minimally invasive surgical procedures for the treatment of lower back pain.
“I am so thrilled to join Aurora, I see the ZIP ISP fusion deviceand pipeline of product developments helping to change the wayspine surgeons fundamentally treat their patients. Add to that the collective spirit already within the team and I have no doubt we will succeed”
Mr. Moss served as International Sales and Marketing Manager at Atlantech Medical Devices Ltd., Harrogate, UK, a privately traded UK developer and manufacturer of Arthroscopic implants and instruments. He later served as Director of Sales EMEA Sports Medicine for the ArthroCare Corporation based in Austin TX, a publicly traded multi-business medical device company that develops, manufactures and markets products. Hespecializes in international sales management and distribution management.Before joining ArthroCare, he served as International Sales and Marketing Manager - Atlantech Medical Devices Ltd., Harrogate, UK, a privately traded UK developer and manufacturer of Arthroscopic implants and instruments.
Aurora Spine specializes in minimally-invasive (MIS), regenerative technologies. Our mission is to be the leader in advanced spinal innovations which will have a positive impact on lives worldwide.
“I am so thrilled to join Aurora, I see the ZIP ISP fusion deviceand pipeline of product developments helping to change the wayspine surgeons fundamentally treat their patients. Add to that the collective spirit already within the team and I have no doubt we will succeed”
Mr. Moss served as International Sales and Marketing Manager at Atlantech Medical Devices Ltd., Harrogate, UK, a privately traded UK developer and manufacturer of Arthroscopic implants and instruments. He later served as Director of Sales EMEA Sports Medicine for the ArthroCare Corporation based in Austin TX, a publicly traded multi-business medical device company that develops, manufactures and markets products. Hespecializes in international sales management and distribution management.Before joining ArthroCare, he served as International Sales and Marketing Manager - Atlantech Medical Devices Ltd., Harrogate, UK, a privately traded UK developer and manufacturer of Arthroscopic implants and instruments.
Aurora Spine specializes in minimally-invasive (MIS), regenerative technologies. Our mission is to be the leader in advanced spinal innovations which will have a positive impact on lives worldwide.
Subscribe to:
Posts (Atom)